NEW YORK (360Dx) – Streck and HiSS Diagnostics announced on Wednesday a distribution agreement covering Streck's molecular and cell stabilization products.
Streck's cell stabilization products include Cell-Free DNA Urine Preserve for stabilizing cell-free DNA in urine; Cell-Free DNA BCT CE, a direct-draw blood collection tube that stabilizes nucleated blood cells and prevents genomic DNA from being released; and Cell-Free RNA BCT CE, a blood collection tube for stabilizing circulating RNA in plasma and preventing the release of non-target background RNA from blood cells during sample processing and storage.
The tubes are not for sale in the US.
Streck's molecular products include Streck Antibiotic Resistance Monitoring and Detection kits, PhilisaFast DNA Polymerase, and Streck's real-time PCR system, the Zulu RT.
Financial and other terms of the deal were not disclosed.